You clearly should stop posting because your knowledge base is horrible.
At the Roth Growth Stock conference, Conroy mentioned there will be a "Training Set" with 100+/100- samples and a "Test Set" with 200+/200- samples PRIOR to the Validation Study.
On another note, I guess you didn't know that the Pap-Smear test (when it first came out) was only 50% sensitive, yet cervical cancer has practically been eradicated over the years.
You also sound quite ignorant to recent studies in Ontario, Canada (Dr. Nancy Baxter) and Heidelberg, Germany (Dr. Hermann Brenner) that point to the colonoscopy as only being 67% sensitive to detecting cancer.
By the way, any secondary offering of stock won't occur until AFTER the Validation Study results are released.
You really should stop posting, because you are totally ignorant of the process here.
In fact, I seem to remember you from your posts on the IBIS message board years ago. You weren't too bright on that board either.